
Myosin is a hexameric protein that makes up about 50% of muscle mass. It is composed of two heavy chains (MHC) and two light chains (MLC). The MHC is a critical structural and enzymatic component of the contractile apparatus of muscle. Myosin ATPase activity catalyzes the cyclical physiochemical interactions of actin and myosin during contraction. The speed of muscle contraction is directly related to the ATPase activity of myosin. This activity is also influenced by the type of muscle fiber, with fast-contracting muscles exhibiting higher ATPase activities than slow-contracting muscles.
| Characteristics | Values |
|---|---|
| Muscle band with ATPase | Myosin |
| Myosin composition | Comprised of two myosin heavy chains (MHC) and two myosin light chains (MLC) |
| Function | Myosin binds to actin to pull it inwards, causing muscle contraction |
| ATPase activity | Inversely proportional to contraction time |
| ATPase activity in fast-contracting vs slow-contracting muscles | Higher in fast-contracting muscles |
| Role of ATP | Provides energy for muscle contraction |
| ATP hydrolysis | Releases inorganic phosphate and energy |
| ATP binding | Causes myosin to release actin |
| ATP and muscle relaxation | ATP hydrolysis changes the angle of the myosin head, and muscle relaxation occurs when actin binding sites are covered |
| Calcium ions | Required for muscle contraction; bind to troponin, leading to conformational changes that allow tropomyosin to uncover myosin-binding sites on actin |
| Types of muscle fibers | Slow oxidative, fast oxidative, and fast glycolytic |
| Slow oxidative fibers | Slow contraction, use aerobic respiration |
| Fast oxidative fibers | Fast contraction, use aerobic respiration |
| Fast glycolytic fibers | Fast contraction, use anaerobic glycolysis, fatigue quickly |
Explore related products
What You'll Learn

Myosin ATPase activity and muscle contraction speed
Myosin is a hexameric protein that comprises two myosin heavy chains (MHC) and four light chains (MLC). It is a molecular motor that powers muscle contraction by transferring energy from the hydrolysis of ATP into the sliding of myofilaments.
The actin-activated myosin ATPase activity catalyses the cyclical physiochemical interactions of actin and myosin during contraction. The intrinsic speed of contraction (sarcomere shortening) is directly proportional to the activity of actin-activated myosin ATPase. This means that the greater the intrinsic speed, the higher the ATPase activity.
Studies have shown that the ATPase activity of myosin isolated from different muscles was inversely proportional to the contraction time of the muscles. This suggests that the ATPase activity of myosin plays a role in determining the speed of muscle contraction.
The relationship between myosin ATPase activity and the speed of muscle contraction has been well-established, with the work of Michael Bárány in 1967 being a milestone in our understanding of the principal determinants of speed, force, and power of muscle contraction. Myosin ATPase activity has been found to predict not only the maximum velocity of shortening of a muscle but also its curvature of the force-velocity relationship and its maximum power-generating capability and peak energetic efficiency.
Furthermore, the kinetic diversity within the myosin superfamily has been described, with myosin isoforms evolving different biochemical reaction rates and force-dependent kinetics to suit their various roles in cell biology.
Magnesium's Impact on Muscle Soreness and Recovery
You may want to see also
Explore related products

Skeletal muscle contraction
Skeletal muscles are found throughout the body and make up about 40% of the human body weight. They are responsible for various functions, including producing movement, maintaining body posture, and stabilizing joints. Unlike smooth and cardiac muscles, skeletal muscle contractions are usually under voluntary control, allowing conscious control of muscles.
The contraction process involves the interaction between actin and myosin, the cyclical physiochemical interactions of which are catalyzed by actin-activated myosin ATPase. Myosin is a hexameric protein composed of two heavy chains (MHC) and two light chains (MLC). The MHC contains the actin-binding regions and the ATPase portions. During contraction, the myosin heads attach to the binding sites on actin, and this attachment is facilitated by the exposure of the active site on actin as calcium binds to troponin.
The myosin head then binds with ATP, leading to its detachment from actin. This detachment is followed by the conversion of ATP to ADP and Pi through the intrinsic ATPase activity of myosin. The energy released during this process changes the angle of the myosin head, positioning it for the next movement. This repetitive movement of the myosin heads is known as the cross-bridge cycle, which requires energy supplied by ATP.
The speed of skeletal muscle contraction is influenced by the activity of actin-activated myosin ATPase. Higher ATPase activity is associated with faster contraction speeds, as observed in fast-twitch muscle fibers. These fast-twitch fibers, or Type IIb fibers, have a high density of actin and myosin proteins, contributing to their rapid contraction capabilities.
Muscle Anatomy: Understanding the Body's Powerhouses
You may want to see also

Smooth muscle MHC isoforms
Smooth muscle myosin heavy chains (MHCs) exist in multiple isoforms. MHC is encoded by a single gene, MYH11, and four MHC isoforms can be generated by alternative splicing, with two of the variants containing differences in the motor domain of the protein. In rabbit smooth muscles, there are at least three types of MHC isoforms: SM1 (204 kD), SM2 (200 kD), and SMemb (200 kD). SM1 and SM2 are specific to smooth muscles, while SMemb is a non-muscle type MHC that is abundantly expressed in the embryonic aorta.
The expression of SM2 mRNA in the fetal aorta is significantly lower compared to SM1 mRNA. However, the ratio of SM2 to SM1 mRNA increases after birth. In humans, the SMemb isoform is detected in the aorta and coronary arteries even in adulthood, unlike in rabbits. Smaller-sized arteries, like the vasa vasorum of the aorta or intramyocardial coronary arterioles, are negative for the SMemb isoform.
The MHC isoforms SM1, SM2, and SMemb have been found to be differentially expressed in rabbits during normal vascular development and in experimental arteriosclerosis and atherosclerosis. With the progression of atherosclerosis, intimal smooth muscles show a decrease in the expression of SM2 and SM1 isoforms. Thus, smooth muscle MHC isoforms are important molecular markers for studying vascular smooth muscle cell differentiation and the cellular mechanisms of atherosclerosis.
One of the main regulators of myosin ATPase activity in smooth muscle and non-muscle cells is myosin light chain kinase (MLCK), which has been widely studied in the context of pathological states associated with increased contractility.
Rehabilitating Atrophied Muscles: Strategies for Strength and Recovery
You may want to see also

Myosin light chain kinase MLCK
Myosin light chain kinase (MLCK) is a key regulator of cellular functions, playing a pivotal role in muscle and non-muscle cellular contraction. MLCK is encoded by the mylk1 and mylk2 genes in mammals, with mylk2 specifically expressed in skeletal muscle cells. MLCK induces contraction by phosphorylating the myosin light chain, which can be enhanced by G-protein-mediated activation.
MLCK has been extensively studied in smooth muscle, but it is also widely distributed in animal cells and tissues. Inhibitors of MLCK, such as ML-9, ML-7, microbial products, and microRNAs, have shown therapeutic potential in treating inflammatory diseases and acting as vasodilators. Abnormal expression of MLCK has been observed in respiratory diseases, pancreatitis, cardiovascular diseases, cancer, and inflammatory bowel disease.
The activity of MLCK is essential for the regulation of smooth muscle contraction, and variations in its content can lead to motility disorders. MLCK has catalytic, inhibitory, and calmodulin-binding domains, and its catalytic activity can be blocked by MLCK inhibitors that bind near the ATP-binding site.
MLCK is also involved in the activation of transient receptor potential (TRP) proteins, specifically the TRPC6 channel. While ML-9 inhibits MLCK activity, studies suggest that ML compounds may inhibit TRPC6 channels independently of MLCK inhibition.
Furthermore, MLCK is one of the main regulators of myosin ATPase activity in smooth muscle and non-muscle cells. Myosin ATPase activity is crucial for muscle contraction, as it catalyzes the cyclical interactions of actin and myosin during this process. The speed of muscle contraction is influenced by myosin ATPase activity, with faster contractions associated with higher ATPase activities.
Explosive Muscle Training: Unlocking the Power Within
You may want to see also

Myosin ATPase and muscle twitch types
Myosin is a hexameric protein composed of two myosin heavy chains (MHC) and two myosin light chains (MLC). It is a crucial component of muscle contractile machinery, constituting about 50% of total muscle protein content. Myosin ATPase, an enzyme that catalyzes the hydrolysis of ATP, plays a central role in muscle contraction. The actin-activated myosin ATPase activity facilitates the cyclical physiochemical interactions between actin and myosin during muscle contraction.
The speed of contraction, or sarcomere shortening, is directly proportional to the activity of actin-activated myosin ATPase. This relationship is evident in experiments where myosin was isolated from muscles with varying contraction times. The results indicated that the ATPase activity of myosin was inversely related to the contraction time, suggesting that myosin ATPase influences the speed of muscle contraction.
Fast-contracting and slow-contracting muscles exhibit differences in their myosin ATPase activities. Fast-contracting muscles, such as Type IIb fibers, have higher myosin ATPase activity, enabling rapid contraction. These fibers are well-suited for intense, short-duration activities like sprinting and weight-lifting. On the other hand, slow-contracting muscles, including slow-twitch skeletal muscles, have lower myosin ATPase activities and are associated with sustained contractions.
The composition of MHC and MLC isoforms varies between slow and fast-twitch muscle fibers. Fast-twitch fibers, characterized by rapid contraction, contain MHC1, MHC2, MHC4, and MLC1. In contrast, slow-twitch fibers, which contract more slowly, are composed of MHC6, MHC7, and MLC3. Mutations in the genes encoding these isoforms, particularly MYH7/MHC7, can lead to myopathies or arthrogryposis, impacting both cardiac and skeletal muscles.
In summary, myosin ATPase is integral to muscle contraction, with its activity influencing the speed of contraction. The distinct characteristics of fast-twitch and slow-twitch muscle fibers, including their MHC and MLC compositions, contribute to the varied myosin ATPase activities observed in different muscle types. Understanding these relationships is crucial for comprehending muscle function and the pathological states associated with altered contractility.
Building Muscle: Unlocking the Science of Growth
You may want to see also
Frequently asked questions
ATPase is an enzyme that binds to myosin and hydrolyzes ATP to ADP, releasing an inorganic phosphate molecule and energy.
ATPase activity in myosin is responsible for determining the speed of muscle contraction. The higher the ATPase activity, the faster the contraction.
ATPase activity varies in different types of muscle fibers, such as slow oxidative, fast oxidative, and fast glycolytic fibers. Fast glycolytic fibers, for example, have high ATPase activity and are best suited for short-duration, intense movements.








